Background The role of mineralocorticoid receptor antagonists (MRAs) in acute myocardial infarction (MI) remains ...

Marijuana is prescribed to help ease chronic pain and control nausea in cancer patients, but legal red tape has made more ...

Argenx SE has discontinued the phase 3 UplighTED studies evaluating efgartigimod subcutaneous (SC) (efgartigimod alfa and hyaluronidase-qvfc) in adults with moderate to severe thyroid eye disease (TED ...

In a groundbreaking first for nutrition science, researchers have published pilot clinical trial data showing that the 5-day Fasting Mimicking Diet (FMD) was associated with increased activity of the ...

PARIS, FRANCE, 19 December 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the pivotal Phase II FALKON trial ...

FDA confirmed that data from single-arm studies in rare diseases, such as in ultra-rare deadly pediatric cancer osteosarcoma, ...

Mortality rates are high in patients with type 1 diabetes, and overweight and obesity appear to be major factors, a speaker ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

As the world's population ages, the number of people living with dementias such as Alzheimer's disease increases.

Introduction Compared with other high-income countries, the USA continues to have the highest rates of pregnancy-related and associated mortality and morbidity (PRAMM), particularly in rural areas and ...

End-of-Phase 2 interactions with FDA complete; scientific advice received from EMA –– Company expects to dose first patient in global Phase 3 ...

Introduction This article outlines the research protocol for a multicentre, randomised, controlled study designed to evaluate the therapeutic effect of a modified olfactory training (MOT) based on ...